Testican-1 Activators
Testican-1 Activators refers to a group of chemical compounds and substances that have demonstrated the capacity to directly or indirectly influence the activity or expression of Testican-1, a proteoglycan found in the extracellular matrix. Testican-1 is known to play a role in various biological processes, including cell adhesion, migration, and tissue remodeling. Activating or modulating Testican-1 through these chemical agents offers insights into the intricate regulatory mechanisms that govern the behavior of this protein and its interactions with other cellular components.
Testican-1 Activators encompass a diverse array of molecules that act upon different aspects of the molecular pathways involved in Testican-1 regulation. Some of these activators may target specific signaling pathways, such as the TGF-beta pathway or the MAPK/ERK pathway, which are known to be linked to Testican-1 functions. These compounds may enhance or inhibit these signaling pathways to fine-tune the expression or activity of Testican-1. Additionally, Testican-1 Activators may influence Testican-1 indirectly by targeting processes like cell adhesion or matrix remodeling. For example, RGD peptides, a class of Testican-1 Activators, contain the RGD motif, promoting cell adhesion to extracellular matrix proteins, thereby indirectly modulating Testican-1's role in cell-matrix interactions. Similarly, matrix metalloproteinase (MMP) inhibitors, which fall under this class, work to prevent the degradation of the extracellular matrix, preserving Testican-1's structural integrity.
SEE ALSO...
Items 1 to 10 of 17 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
This matrix metalloproteinase inhibitor activates Testican-1 by preventing the degradation of the extracellular matrix, indirectly preserving Testican-1 and its function. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
Another matrix metalloproteinase inhibitor that indirectly contributes to activating Testican-1 by maintaining the integrity of the extracellular matrix, including the presence of Testican-1. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
A Wnt pathway modulator that may indirectly activate Testican-1 by impacting Wnt signaling, which can activate extracellular matrix protein expression. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Another Wnt pathway modulator that can indirectly activate Testican-1 by modulating Wnt signaling, a pathway involved in the activation of extracellular matrix proteins. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An NF-κB inhibitor that may indirectly activate Testican-1 by influencing inflammation and tissue remodeling, processes in which Testican-1 participates. | ||||||
BAY 11-7085 | 196309-76-9 | sc-202490 sc-202490A | 10 mg 50 mg | $124.00 $526.00 | 55 | |
Another NF-κB inhibitor that indirectly influences Testican-1 by modulating the NF-κB pathway, related to inflammation and tissue remodeling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K/AKT pathway inhibitor that may indirectly activate Testican-1 by affecting cell survival and extracellular matrix interactions via the PI3K/AKT pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K/AKT inhibitor that indirectly influences Testican-1 by modulating the PI3K/AKT pathway, which can impact cell survival and interactions with the extracellular matrix. | ||||||
PX-478 | 685898-44-6 | sc-507409 | 10 mg | $175.00 | ||
A HIF-1α inhibitor that may indirectly activate Testican-1 by modulating the response to hypoxia, a condition related to extracellular matrix changes and Testican-1 activation. | ||||||
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $33.00 $124.00 $218.00 $947.00 | 9 | |
Another HIF-1α inhibitor that indirectly influences Testican-1 by regulating the response to hypoxia, which can impact extracellular matrix interactions. | ||||||